Candriam Equities L Biotechnology Class R GBP CapRegister to Unlock Ratings |
Growth Of 1000 (GBP) | 30/06/2024 |
|
Annual Returns (GBP) | 30/06/2024 | |||||||
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 30/06 | |
Price Return | 16.63 | -5.01 | 30.77 | 16.46 | -1.00 | 11.79 | 2.00 | 7.03 |
+/- Category | 6.34 | 2.96 | 10.57 | -9.50 | 8.04 | 19.63 | 3.29 | 7.58 |
+/- Category Index | 1.44 | -3.16 | 14.06 | -16.47 | -1.29 | 9.33 | -5.33 | -10.84 |
% Rank in Category | 20 | 33 | 8 | 69 | 34 | 1 | 29 | 17 |
Trailing Returns (GBP) | 15/07/2024 | ||
Total Returns | +/- Category | +/- Category Index | |
1 Day | 0.20 | -0.13 | 0.49 |
1 Week | 4.70 | -1.10 | 3.72 |
1 Month | 6.91 | 4.06 | 5.01 |
3 Months | 12.12 | 9.25 | 0.56 |
6 Months | 8.07 | 6.27 | -8.08 |
YTD | 11.43 | 9.42 | -6.49 |
1 Year | 23.40 | 12.92 | -12.95 |
3 Years Annualised | 8.91 | 12.18 | 0.37 |
5 Years Annualised | 10.56 | 3.18 | -2.32 |
10 Years Annualised* | 12.40 | 2.39 | 0.35 |
Category: Sector Equity Biotechnology | |||
Category Index: Morningstar Gbl Biotechnology NR USD |
Quarterly Returns (GBP) | 30/06/2024 | |||
Quarter 1 | Quarter 2 | Quarter 3 | Quarter 4 | |
2024 | 3.95 | 2.96 | - | - |
2023 | -5.15 | 0.12 | -1.13 | 8.64 |
2022 | -3.81 | 0.13 | 13.67 | 2.12 |
2021 | -5.80 | 6.81 | 0.61 | -2.20 |
2020 | -5.16 | 25.26 | -5.69 | 3.95 |
2019 | 14.08 | 1.91 | -5.67 | 19.24 |
|
Advertisement |